Premium
Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study
Author(s) -
Georgakopoulos J.R.,
Lam K.,
Sandhu V.K.,
Ighani A.,
Phung M.,
Piguet V.,
Yeung J.
Publication year - 2020
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.16366
Subject(s) - secukinumab , medicine , ixekizumab , family medicine , ustekinumab , library science , psoriasis , dermatology , adalimumab , psoriatic arthritis , disease , computer science